The outlook of companies tied to Viagra's legacy presents a intricate investment landscape. While the initial boom generated substantial gains, generic copies have significantly eroded sales . Investing in https://socialicus.com/story7141485/copyright-s-flagship-product-and-big-pharma-a-uncertain-opportunity